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We report three boys (4, 6 and 8 years old) in a Japanese family with X-linked (XL) re-
cessive severe mental retardation (MR), rigidospastic diplegia, mild athetotic movement 
of the upper limbs, delayed myelination and poor weight gain.  Neurological manifes-
tations were non-progressive. No deterioration of development, convulsion, cerebellar 
signs, dysarthria, pseudobulbar signs, or minor anomalies including facial dysmorphism 
or macro-orchidism were found.  Ocular fundus was normal.  The patients’ mothers and 
one grandmother were clinically normal.  Blood chemistry was within normal limits. 
Serum anti-human T-cell leukemia virus-I antibody titer was negative.  Levels of plasma 
amino acids and serum very long chain fatty acids, and lysozomal enzyme activities 
from leukocytes were normal.  Brain magnetic resonance imaging scans showed delayed 
myelination.  Fragile X (FRAXA), fragile XE (FRAXE), proteolipid protein and L1 cell 
adhesion molecule (L1CAM) genes were normal. These ﬁndings were not consistent with 
previously reported 13 XLMR syndromes with paralysis.  We conclude that this condi-
tion is a distinct and previously undescribed XLMR syndrome. 
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The frequency of mental retardation (MR) is es-
timated to be 1 to 3% according to WHO criteria 
(intelligence quotient less than 70) (Roeleveld 
et al., 1997), and X-linked mental retardation 
(XLMR) accounts for a quarter of all MR in 
males (Turner and Opitz, 1980).  Signiﬁcant prog-
ress has been made in research in the XLMR ﬁeld 
(Lubs et al., 1999; Cabezas et al., 1999; Hamel et 
al., 2000; Chiurazzi et al., 2004), and a number of 
XLMR genes have been mapped and cloned re-
cently.  We report on three patients in a Japanese 
family with XLMR associated with rigidospastic 
diplegia, mild athetotic movement of the upper 
limbs, delayed myelination and poor weight gain, 
as a possible previously undescribed syndrome. 
Patients and Methods
Clinical reports 
 
The pedigree is given in Fig. 1.  Two mothers (II-5 
H. Ehara et al.
78
and 7) and one grandmother (I-2) were clinically 
normal.
 
Patient 1 (III-7)
 
Patient 1 was born at 40 weeks of gestation with 
a birth weight of 3490 g after an uncomplicated 
pregnancy to healthy, nonconsanguineous parents 
(mother, age 35, father 43).  His Apgar score was 
10.  On day 6, phototherapy was carried out for 
24 h since the serum total bilirubin level reached 
337 µmol/L.  He had controlled head movements 
at 3 months of age.  Poor weight gain (6230 g) 
was noted at 5 months of age.  He rolled over 
at 6 months of age.  Hypertone of the lower ex-
tremities, developmental delay and poor weight 
gain (6580 g) were noted at 8 months of age at 
a general hospital.  Delay of myelination at the 
5-month level was also noticed on brain magnetic 
resonance imaging (MRI). 
 He was admitted to Tottori University Hos-
pital for further examination at 11 months of 
age.  His height was 74.0 cm (mean), weight 6.97 
kg (–2.3 SD) and occipito-frontal circumference 
(OFC) 44.5 cm (–1.0 SD) on admission.  His 
developmental quotient (DQ) was about 50. 
Other clinical and laboratory findings are sum-
marized in Table 1.  Motor nerve conduction 
velocity of the right median nerve, auditory brain-
stem responses, visual evoked potentials and elec-
trically elicited blink reﬂex were normal.  Latency 
of N20 of short-latency evoked potentials was 
markedly delayed bilaterally.  Brain MRI scans at 
11 months of age showed a 7-month myelination 
level (about 70% of the normal level).
 His stature at the age of 4 years 11 months 
is shown in Table 1.  His DQ was about 20 (he 
walked with support, spoke no words and identi-
ﬁed eyes, ears and mouth).  Rigidospastic diple-
gia with a mild athetotic movement of the upper 
limbs was noted. 
 
Patient 2 (III-9)
 
This child was born at 39 weeks of gestation 
with a birth weight of 2938 g after an uncompli-
cated pregnancy to healthy, nonconsanguineous 
Japanese parents (mother, age 29, father 31).  His 
Apgar score was 9.  On day 5, phototherapy was 
carried out for 24 h.  He could control his head 
at 4 months and rolled over at 6 months of age. 
MRI scans at 6 months of age showed a 4-month 
myelination level (about 70% of the normal level). 
His DQ was about 50 at 11 months of age.  Clini-
cal and laboratory findings are summarized in 
Table 1.  His development and athetoid move-
ments were the same as those in Patient 1.
 
Patient 3 (III-10)
 
Patient 3 was born at 40 weeks of gestation with 
a birth weight of 3060 g after an uncomplicated 
pregnancy (mother, age 31, father 33).  His Apgar 
score was 9.  On day 3, serum total bilirubin level 
increased but phototherapy was not carried out. 
He was able to control his head at 3 months and 
rolled over at 8 months of age.  He was diagnosed 
as having cerebral palsy.  His height was 74.0 cm 
(mean), weight 6.97 kg (–2.3 SD) and OFC 44.5 
cm (–1.0 SD) at 9 months of age.  Brain MRI 
scans at 9 months of age showed a 6-month my-
elination level (about 70% of the normal level). 
He sat at 1 year 5 months of age.  DQ was about 
50 at 2 years and 1 months of age.  Clinical and 
laboratory findings are summarized in Table 1. 
His development and athetoid movements were 
the same as those in Patient 1. 
Fig. 1.  Pedigree of the family.  , affected male; , 
carrier female.
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Molecular analyses
 
We investigated fragile X (FRAXA) and fragile 
XE (FRAXE) genes of the three patients, the 
proteolipid protein gene of Patient 1 and L1 cell 
adhesion molecule (L1CAM) genes of all three 
patients using molecular methodology.  After ob-
taining informed consent, genomic DNAs were 
isolated from peripheral blood lymphocytes of the 
patients for study.  FRAXA, FRAXE and proteo-
lipid protein genes were analyzed according to the 
method described in previous research (Nanba et 
al., 1995; Yamamoto et al., 1998).  No abnormal 
ﬁndings were detected. 
 Genetic analysis of L1CAM was performed 
by DNA sequencing as previously described 
(Okamoto et al., 2004; Kanemura et al., 2005). 
Brieﬂy, ampliﬁcation of the exons and the exon-
intron boundaries of the L1CAM gene was per-
formed by PCR using oligonucleotide primers 
(Jouet et al., 1994).  The puriﬁed PCR ampliﬁca-
tion products were directly sequenced using an 
ABI BigDye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems, Foster City, 
CA).  DNA sequencing was carried out in both 
directions for each template.  No mutation was 
detected in all exons and exon-intron boundaries 
in the three patients.  The research protocol on 
L1CAM gene analysis was approved by the Medi-
cal Research Board of the Ethics Committee of 
Osaka National Hospital. 
 
Table 1. Clinical and laboratory ﬁndings in three patients
  Patients
 III-7 III-9 III-10
Age  4 years 11 months 8 years 11 months 6 years 10 months
Birth weight (g)  3490 2938 3060
Phototherapy  + + –
Transient poor weight gain  + + +
Physical ﬁndings Stature (SD)
      Height/weight/OFC –0.6/–2.1/–1.1  –0.8/–1.6/–1.0  –0.8/–1.0/–2.0
 Minor anomalies – – –
 Hepatosplenomagely – – –
 Macroorchidism – – –
 Ocular fundus N N N
Neurological ﬁndings DQ < 20 < 20 < 20
 Rigidospastic diplegia + + +
 Athetoid movements (mild) + + +
Laboratory ﬁndings Transaminases N N N
 Amino acids (plasma) N N N
 Organic acids (urine) N N N
 VLCFA (serum) N N N
 Lysozomal enzymes (leukocytes) N N N
 Anti-HTLV-I antibody nt – –
 T-cell subsets N N N
 Karyotype (G-banding) N N N
 FRAXA/FRAXE genes N N N
 Proteolipid protein gene N nt nt
 L1CAM gene N N N
 Electroencephalogram N N N
 Delayed myelination on MRI + (11 months) + (6 months) + (9 months)
DQ, developmental quotient; FRAXA, fragile X; FRAXE, fragile XE; HTLV-I, human T-cell leukemia virus-I; 
L1CAM, L1 cell adhesion molecule; MRI, magnetic resonance imaging; N, normal; nt, not tested; OFC, occipito-
frontal circumference; VLCFA, very long chain fatty acid. 
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Discussion
 
Three affected patients in this family were char-
acterized by severe MR, rigidospastic diplegia, 
mild athetotic movement of upper limbs, delayed 
myelination on MRI and transient poor weight 
gain.  Neurological ﬁndings were nonprogressive. 
Deterioration of development, convulsion, cer-
ebellar signs (ataxia and nystagmus), dysarthria, 
pseudobulbar sign, minor anomalies including 
facial dysmorphism, hepatosplenomagaly, sco-
liosis and joint contractures were not observed. 
No abnormal ocular and auditory findings were 
found.  Results of various biochemical analyses 
and anti-human T-cell leukemia virus-I antibody 
titers were normal. Repeat expansions were not 
detected at FRAXA and FRAXE sites.  No mu-
tation was detected in all exons and exon-intron 
boundaries of L1CAM gene.  These ﬁndings were 
almost consistent in all affected patients (Table 1). 
XL recessive inheritance is most likely since all 
patients are male, female siblings were unaffected 
and both mothers and one grandmother are neu-
rologically normal. 
 For differential diagnosis, a review by 
Chiurazzi et al. (2004), in which a total of 209 
XLMR conditions (135 recessive and eight domi-
nant disorders, and 66 nonspeciﬁc XLMR condi-
tions are listed) was searched.  Information from 
the “XLMR Update WebSite” last updated on 1 
September 2005 by Pietro Chiurazzi [http://xlmr.
interfree.it/home.htm] and PubMed [http://www.
ncbi.nlm.nih.gov.] up until November 2005 were 
Table 2. Differential diagnosis: X-linked mental retardation syndromes with spastic paralysis*
          Syndrome OMIM                    Reference         Additional signs and symptoms
PPM-X  300055 Lindsay et al.  [1996] Psychosis, macroorchidism
Spastic paraplegia 16 300266 Steinmuller et al.  [1997] Aphasia, reduced vision, dysfunction of 
        bowel/bladder
Allan-Herndon-Dudley 300523 Stevenson et al.  [1990] Characteristic face, ataxia, athetoid 
        movements
Cantagrel  300524 Cantagrel et al.  [2004] Mild facial dysmorphia, stereotypic 
        movements
JARID1C-related XLMR 300534 Claes et al.  [2000] Facial hypotonia, maxillary hypoplasia
ATR-X syndrome 301040 Martinez et al.  [1998] Short stature, facial dysmorphism, 
        microcephaly
Cerebellar ataxia 2 302500 Apak et al.  [1989] Spinocerebellar ataxia
MASA (L1CAM) 303350 Fransen et al.  [1997] Aphasia, shufﬂing gait, adducted thumbs
Renpenning syndrome 309470 Sutherland et al.  [1988] Short stature, microcephaly, small testis
Fitzsimmons  309560 Fitzsimmons et al.  [1983] Pes cavus, palmoplantar hyperkeratosis
Smith-Fineman-Myers 309580 Guion-Almeida et al. [1998] Unusual facial appearance, seizures, 
        deafness
Schimke XLMR 312840 Schimke et al.  [1984] Choreoathetosis, deafness, 
        ophthalmoplegia
Spastic paraplegia 2 (PLP1) 312920 Cailloux et al.  [2000] Dysarthria, nystagmus, optic atrophy
Hooft   Hooft et al.  [1968] Choreo-athetosis, microcephaly, peculiar 
        appearance
Siber   Siber [1984] Microphthalmia with corneal opacities, 
        hypospadias
Arena   Arena et al.  [1992] Ataxia, titubation, iron deposits in basal 
        ganglia
 ATR-X, X-linked alpha-thalassemia/mental retardation; JARID1C, Jumonji AT-rich interactive domain 1C; L1CAM, 
L1 cell adhesion molecule; OMIM, Online Mendelian Inheritance in Man; PLP, proteolipid protein; XLMR, 
X-linked mental retardation.
* Pyramydal sign or spasticity is included.
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searched as well.  From a total of 40 distinct 
conditions in which XLMR was associated with 
paralysis (spastic paraplegia, diplegia, quadriple-
gia or pyramidal tract signs) selected from these 
three literature sources, 24 conditions were ex-
cluded because of progressive course [MR with 
spastic paraplegia (Davis et al., 1981), XLMR 
with progressive spasticity (Meloni et al., 2000), 
etc.], hydrocephalus [Fried syndrome (Strain et 
al., 1997)], cerebral and cerebellar malforma-
tions [Pettigrew/MRXS5 syndrome (Pettigrew et 
al., 1991, etc.)], myoclonic epilepsy [myoclonic 
epilepsy with MR (Scheffer et al., 2002), etc.], 
blindness [(Hamel BCD syndrome (Hamel et al., 
1999)], etc.  Consequently, 16 entities are listed in 
Table 2. 
 One of the characteristic findings in our 
patients is delayed myelination on MRI.  With 
the development of MRI diagnostics, this ﬁnding 
would be expected more frequently.  We analyzed 
the PLP gene implicated in myelination by means 
of single strand conformation polymorphism 
(SSCP), which proved normal.  No mutation was 
detected in all exons and exon-intron boundaries 
of the L1CAM gene as well.  Our cases had mild 
athetotic movements in the upper limbs besides 
MR and diplegia.  Choreoathetosis has been de-
scribed in several XLMR syndromes associated 
with spasticity.  Baar and Gabriel (1966) and 
Bundy and Grifﬁths (1977) [OMIM 312890], both 
of which were incorporated into spastic paraple-
gia 2 [OMIM 312920], reported this as related 
to athetotic movements, ataxia and nystagmus. 
Hooft et al. (1968) and Schimke et al. (1984) also 
reported families with choreoathetosis which are 
unequivocally different from our cases.  Bialer et 
al. (1992) reported a family in which nine men in 
three generations presented spastic quadriparesis 
and varying degrees of psychomotor retardation. 
Although they had some similarities to the present 
patients, characteristic facial expression, muscle 
hypoplasia, progressive paresis and pseudobulbar 
signs were not recognized in our patients.  To 
our knowledge, there are no reports of the same 
condition in the literature despite our extensive 
search.  We conclude that our cases represent a 
new XLMR syndrome with rigidospastic diplegia 
based on the above sources.
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